• linkedin
  • Increase Font
  • Sharebar

    Botulinum toxin a possible therapeutic option for rosacea

    Research indicates the neuromodulator may affect a neurogenic component that influences vascular dysfunction, inflammation and hypersebaceous activity

    Orlando, Fla. — Botulinum toxin type A (BoNTA) may provide a reasonable therapeutic option for some patients with rosacea, according to experts who spoke at the Orlando Dermatology meeting recently.

    “It’s very important for us to be aware that we have a limited understanding of all that botulinum toxin A is doing within the skin,” says Erin Gilbert, M.D., Ph.D. “We have been using it for more than 15 years clinically for its cosmetic benefits, and we have not begun to address the potential therapeutic power of this drug.” Dr. Gilbert is assistant professor of dermatology at SUNY Downstate Medical Center, New York.

    Related article: Neuromodulators may be effective therapy for psoriasis

    Among skin diseases, she says, “We know that the etiology of rosacea is multifactorial. For most people, there’s a strong inflammatory component.” As a clinician and researcher, she adds, “I approach rosacea from the perspective of neuroinflammation. We know that neuropeptide genes are dysregulated in rosacea. One of the relevant peptides may be vasoactive intestinal protein (VIP) peptide, while calcitonin gene-related peptide (CGRP) appears to play a larger role. These are common themes that are seen across the board in neuroinflammatory disorders.”


    Next: Research looks to identify targets or mechanisms of action



    More on rosacea and BoNTA therapy

    Study finds evidence for rosacea subtype progression

    Clues about rosacea pathogenesis spark treatment advances


    John Jesitus
    John Jesitus is a medical writer based in Westminster, CO.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Latest Tweets Follow